In this exciting webinar, Coach Beverly walks participants through the Management of Hyperglycemia in Type 2 Diabetes as outlined by the most recent American Diabetes Association (ADA) guidelines
(2024) Neurogastroenterology & Motility Mechanistic animal study examining the neural and receptor mechanisms underlying GLP-1-mediated nausea and gastric dysmotility with retatrutide
The European Medicines Agency reviewed semaglutide and liraglutide in 2023 and 2024 and concluded that the available evidence didnt support a causal link with suicidal ideation
Vascular phase (BPC-157): BPC-157 stimulates angiogenesis via the VEGF pathway, ensuring the supply of oxygen and nutrients needed for tissue reconstruction
In alignment, AHAs CKM syndrome model classifies excess weight and adiposity at an early stage (stage 1), defined by established criteria such as BMI and waist circumference, with no other metabolic risk factors at this stage [7]
This measurement does not tell me how much actual tirzepatide I am injecting